Verapamil hydrochloride tablet extended release labels and packages: Difference between revisions
Created page with "__NOTOC__ {{Verapamil}} {{CMG}}; {{AE}} {{AK}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = CALAN SR (VERAPAMIL HYDROCHLORIDE) TABLET, FILM CO..." |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AK}} | {{CMG}}; {{AE}} {{AK}} | ||
==LABELS AND PACKAGES== | |||
LAB-0268-7.0 | |||
October 2013 | |||
PRINCIPAL DISPLAY PANEL - 120 mg Caplet Bottle Label | |||
NDC 0025-1901-31 | |||
100 Caplets | |||
Rx only | |||
Calan® SR | |||
(verapamil hydrochloride) | |||
SUSTAINED-RELEASE | |||
120 mg | |||
Pfizer | |||
Distributed by | |||
G.D. Searle LLC | |||
Division of Pfizer Inc, NY, NY 10017 | |||
{| | |||
| [[image:calansr1.jpg|400px|thumb]] | |||
|} | |||
PRINCIPAL DISPLAY PANEL - 180 mg Caplet Bottle Label | |||
NDC 0025-1911-31 | |||
100 Caplets | |||
Rx only | |||
Calan® SR | |||
(verapamil hydrochloride) | |||
SUSTAINED-RELEASE | |||
180 mg | |||
Pfizer | |||
Distributed by | |||
G.D. Searle LLC | |||
Division of Pfizer Inc, NY, NY 10017 | |||
{| | |||
| [[image:calansr2.jpg|400px|thumb]] | |||
|} | |||
PRINCIPAL DISPLAY PANEL - 240 mg Caplet Bottle Label | |||
NDC 0025-1891-31 | |||
100 Caplets | |||
Rx only | |||
Calan® SR | |||
(verapamil hydrochloride) | |||
SUSTAINED-RELEASE | |||
240 mg | |||
Pfizer | |||
Distributed by | |||
G.D. Searle LLC | |||
Division of Pfizer Inc, NY, NY 10017 | |||
{| | |||
| [[image:calansr3.jpg|400px|thumb]] | |||
|} | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = CALAN SR (VERAPAMIL HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [G.D. SEARLE LLC DIVISION OF PFIZER INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acb6e57b-af44-432f-a4de-a293a2e20121#nlm34090-1 | publisher = | date = | accessdate = }}</ref> | <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = CALAN SR (VERAPAMIL HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [G.D. SEARLE LLC DIVISION OF PFIZER INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acb6e57b-af44-432f-a4de-a293a2e20121#nlm34090-1 | publisher = | date = | accessdate = }}</ref> | ||
Revision as of 21:20, 4 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
LABELS AND PACKAGES
LAB-0268-7.0 October 2013
PRINCIPAL DISPLAY PANEL - 120 mg Caplet Bottle Label
NDC 0025-1901-31
100 Caplets Rx only
Calan® SR (verapamil hydrochloride)
SUSTAINED-RELEASE
120 mg
Pfizer Distributed by G.D. Searle LLC Division of Pfizer Inc, NY, NY 10017
 |
PRINCIPAL DISPLAY PANEL - 180 mg Caplet Bottle Label
NDC 0025-1911-31
100 Caplets Rx only
Calan® SR (verapamil hydrochloride)
SUSTAINED-RELEASE
180 mg
Pfizer Distributed by G.D. Searle LLC Division of Pfizer Inc, NY, NY 10017
 |
PRINCIPAL DISPLAY PANEL - 240 mg Caplet Bottle Label
NDC 0025-1891-31
100 Caplets Rx only
Calan® SR (verapamil hydrochloride)
SUSTAINED-RELEASE
240 mg
Pfizer Distributed by G.D. Searle LLC Division of Pfizer Inc, NY, NY 10017
 |